Multiplex immunofluorescence analysis revealed distinct patterns of CD8+ T cell dynamics: non-responders have a higher overall number of tumor infiltrating lymphocytes (TILs) compared to responders, both before and after cetuximab treatment. The gene discussed is CD8A; the disease is neoplasm.